Getting sick with a common cold doesn't make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number of antibodies you have against common cold-causing coronaviruses and the SARS-CoV-1 ...
May 5, 2022
0
110
During experiments in animal models, researchers at the University of Kansas have discovered a possible new approach to immunization against Alzheimer's disease (AD).
May 3, 2022
0
114
In the majority of cases, children who catch COVID won't end up suffering serious illness. Kids have fewer symptoms, less severe disease, and tend to recover faster than adults.
May 3, 2022
0
7
The omicron variant of SARS-CoV-2 has caused another major wave of infection worldwide. This is because even vaccinated individuals or those who had contracted a previous variant of the virus can become infected with omicron. ...
May 2, 2022
0
107
Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers at Karolinska Institutet in Sweden have now developed a method for identifying the immune cells ...
Apr 27, 2022
0
135
A new study in breast cancer survivors has found that chemotherapy, while a critical part of breast cancer therapy, may also have some lasting dampening effects on natural immunity, but moderate fitness improvements can offer ...
Apr 26, 2022
0
68
New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has identified the third day of hospitalization as a tipping point ...
Apr 23, 2022
0
3
Cancer researchers at Case Western Reserve University School of Medicine say they have successfully suppressed the growth of some solid tumors in research models by manipulating immune cells known as macrophages.
Apr 20, 2022
0
101
With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.
Apr 18, 2022
0
133
In the presence of pancreatic tumors, certain immune cells break down structural proteins into molecules that trigger the building of dense tissue, a known barrier to therapy, a new study finds.
Apr 4, 2022
0
27
